Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dupilumab Therapy for Refractory Eosinophilic Gastrointestinal Disorders in Children

NCT07257835 is registered in ClinicalTrials.gov with Children's Hospital of Fudan University as lead sponsor.

NCT NCT07257835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07257835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dupilumab Therapy for Refractory Eosinophilic Gastrointestinal Disorders in Children
Lead sponsor
Children's Hospital of Fudan University
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2025
Completion date
December 1, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eosinophilic gastrointestinal disorders (egids)